Merck KGaA registers Elowen-LTE Phase 3 lupus study and mirdametinib drug interaction trialSep 25Weekly roundup, 2 itemsMerck KGaAmirdametinib
JAVELIN Bladder Medley posts results; avelumab combos tested as maintenance therapySep 1Trial updateavelumabM6223
Sign in